Target intelligence / Profile preview

Reticulon 3 pseudogene

Molecular classification
Pseudogene, Processed pseudogene
01

Overview

Reticulon 3 pseudogene (ENSG00000258142) is a non-functional genomic element with sequence similarity to the protein-coding reticulon 3 gene. As a pseudogene, it cannot produce functional protein due to disruptive mutations such as frameshifts or premature stop codons. Although pseudogenes were historically considered "junk DNA," research indicates that some may be transcribed and generate non-coding RNAs, which can regulate gene expression or local chromatin states. Processed pseudogenes, the likely category for ENSG00000258142, are typically generated by retrotransposition of mRNA and lack protein-coding capacity due to absence of promoters and disruptive mutations. Pseudogene sequences can interfere with laboratory assays (e.g., PCR) due to high sequence similarity to their parent gene, sometimes leading to ambiguous results or misannotation. However, there is no evidence for reticulon 3 pseudogene as a therapeutic target or biomarker, nor is it known to be implicated in human disease or drug response. Its main relevance is as a genomic feature for annotation, not for molecular pharmacology or clinical research.

Other names
ENSG00000258142
02

Biological functions

Can produce non-coding RNAs with potential regulatory functions (e.g., competing endogenous RNAs, small interfering RNAs, chromatin repression)Generally does not encode functional proteins or canonical gene products
03

Disease associations

No direct evidence of involvement in human pathology for reticulon 3 pseudogeneNot currently known to play a role in specific diseases
04

Safety considerations

May complicate molecular assays (e.g., PCR) due to sequence similarity with the parent gene

Beyond the preview

Go deeper on Reticulon 3 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reticulon 3 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call